Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study.
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, Kurahashi S, Kagoo T, Tanimoto K, Saotome S, Tomiyama Y; R788-1301 Investigators. Kuwana M, et al. Among authors: ito t. Br J Haematol. 2023 Mar;200(6):802-811. doi: 10.1111/bjh.18582. Epub 2022 Dec 5. Br J Haematol. 2023. PMID: 36470677 Clinical Trial.
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.
Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Edahiro Y, Akashi K, Matsumura I, Takenaka K, Komatsu N. Hashimoto Y, et al. Among authors: ito t. Int J Hematol. 2022 Feb;115(2):208-221. doi: 10.1007/s12185-021-03253-0. Epub 2021 Nov 2. Int J Hematol. 2022. PMID: 34727329
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.
Edahiro Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Hashimoto Y, Akashi K, Matsumura I, Takenaka K, Komatsu N. Edahiro Y, et al. Among authors: ito t. Int J Hematol. 2022 Nov;116(5):696-711. doi: 10.1007/s12185-022-03412-x. Epub 2022 Jul 9. Int J Hematol. 2022. PMID: 35809214
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, Kurahashi S, Kagoo T, Tanimoto K, Saotome S, Tomiyama Y. Kuwana M, et al. Among authors: ito t. Am J Hematol. 2024 Feb;99(2):E55-E59. doi: 10.1002/ajh.27176. Epub 2024 Jan 2. Am J Hematol. 2024. PMID: 38165064 Clinical Trial. No abstract available.
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.
Ito T, Hashimoto Y, Tanaka Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Konishi A, Hotta M, Yoshimura H, Ishii K, Hashimoto A, Kondo T, Omura H, Shinzato I, Tanaka T, Nomura S. Ito T, et al. Eur J Haematol. 2019 Aug;103(2):116-123. doi: 10.1111/ejh.13265. Epub 2019 Jun 17. Eur J Haematol. 2019. PMID: 31107982 Free PMC article.
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience.
Konishi A, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Saito R, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S. Konishi A, et al. Among authors: ito t. Leuk Res Rep. 2019 Mar 5;11:11-13. doi: 10.1016/j.lrr.2019.03.002. eCollection 2019. Leuk Res Rep. 2019. PMID: 30911464 Free PMC article.
11,330 results
You have reached the last available page of results. Please see the User Guide for more information.